Epidemics of meningococcal meningitis in Northern Nigeria focus on preventive measures

Modelling meningococcal meningitis in the African meningitis belt

Meningococcal meningitis is a major public health problem in a large area of sub-Saharan Africa kno

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines

Abstract The introduction and rollout of a meningococcal serogroup A conjugate vaccine, MenAfriVac,

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac® in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa

For more than a century, epidemic meningococcal disease mainly caused by serogroup A Neisseria menin

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study

Background: A serogroup

Evaluation of the meningitis epidemics risk model in Africa

Meningitis epidemics have a strong environmental component in Africa with the most severe epidemics

Effects of adopting preventive measures on malaria parasitemia among pregnant women in Kaduna state, Nigeria